| Amanda L Mayle, PSYD, HSPP | |
|
11141 Parkview Plaza Dr Ste 210, Fort Wayne, IN 46845-1714 | |
| (260) 266-5400 | |
| (260) 266-5409 |
| Full Name | Amanda L Mayle |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 11141 Parkview Plaza Dr Ste 210, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003865395 | NPI | - | NPPES |
| 200802600 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 20042046A (Indiana) | Primary |
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
Cancer is a natural consequence of human evolution. Our genes have not developed to give us long and happy lives.
Gelesis, Inc., a biotechnology company developing a novel category of therapies to safely induce weight loss, improve glycemic control, and treat other chronic diseases related to the gastrointestinal (GI) pathway, is pleased to report today that the last patient has completed treatment in the pivotal GLOW (Gelesis Loss Of Weight) Study.
Leading research and clinical experts from around the world are scheduled to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be held October 17 to 20 in the Washington, D.C. area.
Five teams of scientists earned research seed grants awarded this year by the John S. Dunn Foundation. The awards support new collaborations by researchers at Rice University's BioScience Research Collaborative (BRC) and their partners at other institutional members of the Gulf Coast Consortia (GCC).
Talecris Biotherapeutics Holdings Corp. ("Talecris") today announced the launch of its initial public offering of 44,736,842 shares of its common stock, par value $0.01 per share.
› Verified 7 days ago
| Entity Name | Park Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306897004 PECOS PAC ID: 5991794794 Enrollment ID: O20041213000226 |
News Archive
Cancer is a natural consequence of human evolution. Our genes have not developed to give us long and happy lives.
Gelesis, Inc., a biotechnology company developing a novel category of therapies to safely induce weight loss, improve glycemic control, and treat other chronic diseases related to the gastrointestinal (GI) pathway, is pleased to report today that the last patient has completed treatment in the pivotal GLOW (Gelesis Loss Of Weight) Study.
Leading research and clinical experts from around the world are scheduled to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be held October 17 to 20 in the Washington, D.C. area.
Five teams of scientists earned research seed grants awarded this year by the John S. Dunn Foundation. The awards support new collaborations by researchers at Rice University's BioScience Research Collaborative (BRC) and their partners at other institutional members of the Gulf Coast Consortia (GCC).
Talecris Biotherapeutics Holdings Corp. ("Talecris") today announced the launch of its initial public offering of 44,736,842 shares of its common stock, par value $0.01 per share.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda L Mayle, PSYD, HSPP 11109 Parkview Plaza Dr # 117, Fort Wayne, IN 46845-1701 Ph: () - | Amanda L Mayle, PSYD, HSPP 11141 Parkview Plaza Dr Ste 210, Fort Wayne, IN 46845-1714 Ph: (260) 266-5400 |
News Archive
Cancer is a natural consequence of human evolution. Our genes have not developed to give us long and happy lives.
Gelesis, Inc., a biotechnology company developing a novel category of therapies to safely induce weight loss, improve glycemic control, and treat other chronic diseases related to the gastrointestinal (GI) pathway, is pleased to report today that the last patient has completed treatment in the pivotal GLOW (Gelesis Loss Of Weight) Study.
Leading research and clinical experts from around the world are scheduled to speak at the 2nd International Symposium for MR-guided Focused Ultrasound, which will be held October 17 to 20 in the Washington, D.C. area.
Five teams of scientists earned research seed grants awarded this year by the John S. Dunn Foundation. The awards support new collaborations by researchers at Rice University's BioScience Research Collaborative (BRC) and their partners at other institutional members of the Gulf Coast Consortia (GCC).
Talecris Biotherapeutics Holdings Corp. ("Talecris") today announced the launch of its initial public offering of 44,736,842 shares of its common stock, par value $0.01 per share.
› Verified 7 days ago
Dr. Michelle Renne Miller, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4630 W Jefferson Blvd, Ste 11a, Fort Wayne, IN 46804 Phone: 260-434-1606 Fax: 260-434-1612 | |
Dr. Victor L Rebman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1910 Saint Joe Center Rd, Office #63, Fort Wayne, IN 46825 Phone: 260-471-9902 Fax: 260-471-9902 | |
Jason T. Cook, PSY.D., HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7230 Engle Rd, Ste 304, Fort Wayne, IN 46804 Phone: 260-483-2400 Fax: 260-960-9361 | |
Dr. Galen Arthur Yordy, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2805 Fairfield Ave, Fort Wayne, IN 46807 Phone: 260-456-4880 Fax: 260-456-3559 | |
Dr. Kelly Stewart Hutner, PSY.D., HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 11143 Parkview Plaza Dr Ste 320, Fort Wayne, IN 46845 Phone: 260-266-5370 Fax: 260-266-5379 | |
Dr. Bruce Edward Nerenberg, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 2121 Lake Ave, Fort Wayne, IN 46805 Phone: 800-360-8387 Fax: 260-460-1481 |